Aspire Biopharma Holdings, Inc.
ASBP
$0.11
$0.0113.05%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.85M | -1.98M | -15.94M | -738.50K | -216.30K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 2.02M | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.59M | 1.18M | 14.52M | -- | -- |
| Change in Net Operating Assets | 318.40K | -340.40K | -326.30K | 1.22M | -279.30K |
| Cash from Operations | -1.10M | -1.14M | -1.75M | 479.60K | -495.50K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 38.30K |
| Total Debt Issued | 7.25M | 0.00 | 3.05M | -492.50K | 492.50K |
| Total Debt Repaid | -3.50M | 0.00 | -221.40K | -- | -- |
| Issuance of Common Stock | -- | 265.80K | -- | -- | 0.00 |
| Repurchase of Common Stock | -265.80K | -- | -- | -257.60K | -- |
| Issuance of Preferred Stock | -- | -- | -- | 257.60K | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -641.70K | -265.80K | 265.80K | -- | -- |
| Cash from Financing | 2.85M | 0.00 | 3.09M | -492.50K | 492.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.74M | -1.14M | 1.34M | -12.90K | -3.10K |